Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMC 4265716)

Published in Korean J Urol on December 05, 2014

Authors

Ali Cyrus1, Ali Kabir2, Davood Goodarzi1, Afsaneh Talaei3, Ali Moradi4, Mohammad Rafiee5, Mehrdad Moghimi6, Elham Shahbazi7, Elaheh Farmani7

Author Affiliations

1: Department of Urology, Arak University of Medical Sciences, Arak, Iran.
2: Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, and Department of Epidemiology, Faculty of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3: Department of Endocrinology, Arak University of Medical Sciences, Arak, Iran.
4: Asadabad Health and Treatment Network, Hamedan University of Medical Sciences, Hamadan, and Department of Epidemiology, Faculty of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5: Department of Statistics, Arak University of Medical Sciences, Arak, Iran.
6: Department of Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
7: Arak University of Medical Sciences, Arak, Iran.

Articles cited by this

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care (2004) 3.87

The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol (2004) 2.24

The correlation between metabolic syndrome and prostatic diseases. Eur Urol (2011) 1.83

Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) (2005) 1.82

Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology (2003) 1.78

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol (2006) 1.69

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta (2006) 1.44

Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev (2004) 1.39

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control (2009) 1.33

Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men. BJU Int (2008) 1.08

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int (2007) 1.07

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. BJU Int (2010) 1.06

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05

Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol (2013) 1.04

Prostate volume measurement by TRUS using heights obtained by transaxial and midsagittal scanning: comparison with specimen volume following radical prostatectomy. Korean J Radiol (2001) 1.02

Metabolic syndrome. Indian J Med Sci (2006) 1.01

Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiol Biomarkers Prev (2008) 1.00

Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol (2013) 0.95

Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men. World J Mens Health (2012) 0.94

Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age. Korean J Urol (2011) 0.93

Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. J Korean Med Sci (2011) 0.92

The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population. Cancer Epidemiol Biomarkers Prev (2010) 0.88